drugset / Trial / NCT04855383

Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

NCT04855383

Completed 200 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran.

Timeline

Start
2020-07-01
Primary completion
2022-08-22
Completion
2023-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 5000 iu Intramuscular

Indications

No indication recorded.